Cannabis-Related Disorders and Toxic Effects | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Cannabidiol (CBD) has shown promise in treating psychiatric disorders, including cannabis
use disorder–a major public health burden with no approved pharmacotherapies. However …

Cannabis is well established to impact affective states, emotion and perceptual processing,
primarily through its interactions with the endocannabinoid system. While cannabis use is …

The legalization of cannabis in many countries, as well as the decrease in perceived risks of
cannabis, have contributed to the increase in cannabis use medicinally and recreationally …

Abstract Purpose of Review With cannabis legalization expanding throughout the world, an
unprecedented number of people now have access to legal cannabis. This expanded …

Cannabis has been legalized for medical and recreational purposes in multiple countries. A
large number of people are using cannabis and some will develop cannabis use disorder …

Background: The endogenous cannabinoid system (ECS), including the endocannabinoids
(eCBs), anandamide (AEA), and 2-arachidonoylglycerol (2-AG), plays an integral role in …

Societal attitudes toward cannabis, both as a drug of abuse and as a potential therapeutic,
have undergone a marked shift in the past 25 years, resulting in wide-scale changes in …

Cannabis self-administration studies may be helpful for identifying factors that influence
cannabis consumption and subjective response to cannabis. Additionally, these paradigms …